Meeting NewsVideo

VIDEO: Neurotech implant shows positive safety profile

SAN FRANCISCO — At the Glaucoma 360: New Horizons Forum, Jeffrey L. Goldberg, MD, PhD, professor and chair of ophthalmology at Byers Eye Institute at Stanford University, discusses phase 2 data regarding an implant from Neurotech that releases ciliary neurotrophic factor.

SAN FRANCISCO — At the Glaucoma 360: New Horizons Forum, Jeffrey L. Goldberg, MD, PhD, professor and chair of ophthalmology at Byers Eye Institute at Stanford University, discusses phase 2 data regarding an implant from Neurotech that releases ciliary neurotrophic factor.

    See more from Glaucoma 360